EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema

Pascal Brouillard, Aino Murtomäki, Veli-Matti Leppänen, Marko Hyytiäinen, Sandrine Mestre, Lucas Potier, Laurence M Boon, Nicole Revencu, Arin Greene, Andrey Anisimov, Miia H Salo, Reetta Hinttala und 4 weitere

Journal of Clinical Investigation · 15.07.2024 · 134 (14)

DOI: 10.1172/jci173586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 30.05.2024. Verfasst von Pascal Brouillard und 15 weiteren Autor:innen. Beteiligte Einrichtung: Human Molecular Genetics, de Duve Institute, University of Louvain, Brussels, Belgium. Hauptthemen laut MEDLINE: Lymphedema, Receptor, TIE-1, Loss of Function Mutation. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds De La Recherche Scientifique - FNRS, Fund Generet managed by the King Baudouin Foundation, Région wallonne dans le cadre du financement de l’axe stratégique FRFS-WELBIO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary lymphedema (PL), characterized by tissue swelling, fat accumulation, and fibrosis, results from defects in lymphatic vessels or valves caused by mutations in genes involved in development, maturation, and function of the lymphatic vascular system. Pathogenic variants in various genes have been identified in about 30% of PL cases. By screening of a cohort of 755 individuals with PL, we identified two TIE1 (tyrosine kinase with immunoglobulin- and epidermal growth factor–like domains 1) missense variants and one truncating variant, all predicted to be pathogenic by bioinformatic algorithms. The TIE1 receptor, in complex with TIE2, binds angiopoietins to regulate the formation and remodeling of blood and lymphatic vessels. The premature stop codon mutant encoded an inactive truncated extracellular TIE1 fragment with decreased mRNA stability, and the amino acid substitutions led to decreased TIE1 signaling activity. By reproducing the two missense variants in mouse Tie1 via CRISPR/Cas9, we showed that both cause edema and are lethal in homozygous mice. Thus, our results indicate that TIE1 loss-of-function variants can cause lymphatic dysfunction in patients. Together with our earlier demonstration that ANGPT2 loss-of-function mutations can also cause PL, our results emphasize the important role of the ANGPT2/TIE1 pathway in lymphatic function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphedemaReceptor, TIE-1Loss of Function MutationHumansAnimalsMiceFemaleMaleMutation, MissenseAge of OnsetMiddle AgedAdultReceptor, TIE-2

Stichwörter der Autor:innen

Genetic diseasesGeneticsLymphMouse modelsVascular biology

Substanzen

Receptor, TIE-1TEK protein, humanTek protein, mouseReceptor, TIE-2

Autor:innen und Institutionen

  • Human Molecular Genetics, de Duve Institute, University of Louvain, Brussels, Belgium.
  • Wihuri Research Institute, Biomedicum Helsinki, Helsinki, Finland.
  • Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Vascular Medicine, Centre de Référence des Maladies Lymphatiques et Vasculaires Rares, Inserm IDESP, CHU Montpellier, Université de Montpellier, Montpellier, France.
  • Center for Vascular Anomalies, Division of Plastic Surgery, Cliniques Universitaires Saint-Luc, University of Louvain, VASCERN-VASCA Reference Centre, Brussels, Belgium.
  • Center for Human Genetics, Cliniques Universitaires Saint-Luc, University of Louvain, Brussels, Belgium.

Förderung

  • Fonds De La Recherche Scientifique - FNRS
  • Fund Generet managed by the King Baudouin Foundation
  • Région wallonne dans le cadre du financement de l’axe stratégique FRFS-WELBIO
  • Leducq Foundation Networks of Excellence Program
  • European Union’s Horizon 2020 research and innovation programme
  • Wihuri Foundation
  • European research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme
  • Jane and Aatos Erkko Foundation

Zitieren

APA

Brouillard, P., Murtomäki, A., Leppänen, V. M., Hyytiäinen, M., Mestre, S., Potier, L., Boon, L. M., Revencu, N., Greene, A., Anisimov, A., Salo, M. H., Hinttala, R., Eklund, L., Quéré, I., Alitalo, K., & Vikkula, M. (2024). Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema. Journal of Clinical Investigation, 134(14). https://doi.org/10.1172/jci173586

Vancouver

Brouillard P, Murtomäki A, Leppänen VM, Hyytiäinen M, Mestre S, Potier L, et al. Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema. Journal of Clinical Investigation. 2024;134(14). doi:10.1172/jci173586

BibTeX
@article{Brouillard2024,
  author = {Brouillard, Pascal and Murtomäki, Aino and Leppänen, Veli-Matti and Hyytiäinen, Marko and Mestre, Sandrine and Potier, Lucas and Boon, Laurence M and Revencu, Nicole and Greene, Arin and Anisimov, Andrey and Salo, Miia H and Hinttala, Reetta and Eklund, Lauri and Quéré, Isabelle and Alitalo, Kari and Vikkula, Miikka},
  title = {Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {14},
  doi = {10.1172/jci173586}
}
Kostenlos starten →